Trial NCT01256489

View at ClinicalTrials.gov 
Org. Study IDs: 10-02-010
Secondary IDs: 196405

Last trial update was posted on 2015-11-04

MeSH Interventions

Infliximab

MeSH Conditions

Blindness Stevens-Johnson Syndrome Syndrome

Other Conditions

Corneal Blindness

Stopping Reasons

Steven Johnson's Syndrome (SJS) and Toxic Epidermal Necrolysis Syndrome (TENS) are rare (~3 in 1 million). No eligible subjects have been identified.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID